Mayo Clinic Ventures
Mayo Clinic is for the benefit of patients worldwide while generating revenue to support clinical practic.
Business Model:
Revenue: $14B
Employees: 10,001-999,999
Rankings
Industries / Tags:
Detailed Mayo Clinic Ventures Information
Geographic Data
Address: 200 First St. SW,
City: Rochester
State: MN
Zip: 55905
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$262M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicated efforts bring significant financial support to Mayo&s;s patient care, education and research efforts.
Contact Phone:
+15072842511
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2005 | Naviscan | Series B | 6.5M |
| 10/2019 | Atrian Medical | Seed Round | 2.6M |
| 8/2021 | JOGO Health | Seed Round | 0 |
| 11/2021 | Tympany Medical | Seed Round | 0 |
| 8/2017 | UNITY Biotechnology | Series B | 35M |
| 7/2017 | Evelo Biosciences | Series B | 50M |
| 5/2007 | Naviscan | Series C | 15M |
| 1/2015 | Stride Health | Seed Round | 2.4M |
| 4/2009 | Torax Medical | Series C | 15M |
| 6/2005 | Torax Medical | Series B | 10M |
| 7/2016 | Torax Medical | Series E | 0 |
| 6/2021 | Helix | Series C | 50M |
| 11/2017 | Progentec Diagnostics | Venture Round | 1.3M |
| 1/2022 | The Patient Company | Convertible Note | 1M |
| 2/2015 | Lifecode | Series A | 0 |
| 3/2021 | TripleBlind | Seed Round | 0 |
| 12/2019 | Hui-Gene Therapeutics | Series A | 14.2M |
| 12/2020 | nference | Series C | 0 |
| 6/2017 | Vineti | Series A | 13.8M |
| 6/2021 | R-Zero | Series B | 50M |
| 9/2012 | Torax Medical | Series D | 0 |
| 1/2016 | Epirium Bio | Venture Round | 192k |
| 7/2018 | Marigold Health | Pre Seed Round | - |
| 8/2019 | Qlaris Bio | Series A | 8.2M |
| 4/2018 | Geneticure | Seed Round | 1.4M |
| 1/2020 | nference | Series B | 0 |
| 1/2020 | Progentec Diagnostics | Series A | 5M |
| 10/2019 | Cadence Neuroscience | Series A | 15M |
| 12/2022 | Turtle Health | Seed Round | 0 |
| 5/2021 | Anumana | Series B | 60M |
| 8/2007 | Kardia Health Systems | Venture Round | 3.3M |
| 4/2018 | Vineti | Series B | 33.5M |
| 12/2019 | Elysium | Series C | 40M |
| 1/2020 | Novome Biotechnologies | Series A | 0 |
| 2/2021 | Anumana | Series A | 25.7M |
| 11/2021 | Tympany Medical | Seed Round | 0 |
| 6/2021 | R-Zero | Series B | 0 |
| 6/2021 | Helix | Series C | 0 |
| 3/2021 | TripleBlind | Seed Round | 0 |
| 12/2020 | nference | Series C | 0 |
| 1/2020 | Progentec Diagnostics | Series A | 0 |
| 1/2020 | nference | Series B | 0 |
| 1/2020 | Novome Biotechnologies | Series A | 0 |
| 12/2019 | Elysium | Series C | 0 |
| 12/2019 | Hui-Gene Therapeutics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
